Copper in PDB 1dyz: Oxidised Azurin II From Alcaligenes Xylosoxidans

The structure of Oxidised Azurin II From Alcaligenes Xylosoxidans, PDB code: 1dyz was solved by F.E.Dodd, Z.H.L.Abraham, R.R.Eady, S.S.Hasnain, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	8.5 / 1.75
Space group	P 41 2 2
Cell size a, b, c (Å), α, β, γ (°)	52.650, 52.650, 100.630, 90.00, 90.00, 90.00
R / Rfree (%)	18.9 / 20.5

The binding sites of Copper atom in the Oxidised Azurin II From Alcaligenes Xylosoxidans (pdb code 1dyz). This binding sites where shown within 5.0 Angstroms radius around Copper atom.
In total only one binding site of Copper was determined in the Oxidised Azurin II From Alcaligenes Xylosoxidans, PDB code: 1dyz:

Copper binding site 1 out of 1 in the Oxidised Azurin II From Alcaligenes Xylosoxidans


Mono view


Stereo pair view

A full contact list of Copper with other atoms in the Cu binding site number 1 of Oxidised Azurin II From Alcaligenes Xylosoxidans within 5.0Å range: probe atom residue distance (Å) B Occ A:Cu130 b:15.5 occ:1.00 ND1 A:HIS117 2.0 12.5 1.0 ND1 A:HIS46 2.0 11.7 1.0 SG A:CYS112 2.1 11.5 1.0 O A:GLY45 2.7 17.3 1.0 CE1 A:HIS117 2.9 10.8 1.0 CE1 A:HIS46 3.0 11.5 1.0 CG A:HIS117 3.0 13.5 1.0 CG A:HIS46 3.1 11.9 1.0 SD A:MET121 3.3 15.5 1.0 CA A:HIS46 3.3 14.1 1.0 CB A:CYS112 3.3 11.3 1.0 CB A:HIS117 3.4 13.8 1.0 CB A:HIS46 3.5 12.6 1.0 C A:GLY45 3.7 14.5 1.0 CB A:PHE114 3.9 10.6 1.0 CE A:MET121 4.0 13.9 1.0 N A:HIS46 4.0 13.9 1.0 NE2 A:HIS117 4.1 10.0 1.0 NE2 A:HIS46 4.1 9.2 1.0 CD2 A:HIS117 4.1 11.5 1.0 CD2 A:HIS46 4.2 11.1 1.0 C A:HIS46 4.5 14.6 1.0 N A:ASN47 4.5 13.1 1.0 CG A:PHE114 4.6 11.0 1.0 CA A:CYS112 4.7 11.4 1.0 CG A:MET121 4.8 15.5 1.0 CD1 A:PHE114 4.9 11.2 1.0 CA A:HIS117 4.9 14.3 1.0 N A:PHE114 4.9 10.4 1.0

F.E.Dodd, Z.H.L.Abraham, R.R.Eady, S.S.Hasnain. Structures of Oxidised and Reduced Azurin II From Alcaligenes Xylosoxidans at 1.75 Angstoms Resolution Acta Crystallogr.,Sect.D V. 56 690 2000.
ISSN: ISSN 0907-4449
PubMed: 10818345
DOI: 10.1107/S0907444900003309